"Organon Laboratories, part of the Schering-Plough corporation, has announced the discontinuation of Sustanon 100, a testosterone replacement therapy (IM injection) for the treatment of male hypogonadal disorders. Following earlier communications, this discontinuation is effective immediately. The availability of Sustanon 250 is unaffected by this announcement."
I've only just realized that Organon and Schering our now part of the same corporation. I hope no more overlapping products will be discontinued. :-(
No comments:
Post a Comment